Inventor
Maria O. Tinti
Inventor
Rome, IT
Overview
Patents· 82 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
C07Cprimary
C07CAcyclic or carbocyclic compounds28%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations28%
A61KPreparations for medical, dental or toiletry purposes14%
C07DHeterocyclic compounds12%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
A23KFodder2%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for2%
C07KPeptides2%
C07BGeneral methods of organic chemistry2%
A61QSpecific use of cosmetics or similar toiletry preparations1%
PatentTitleYear
8,124,769'Stereoselective process and crystalline forms of a camptothecin'20128,101,758'Stereoselective process and crystalline forms of a camptothecin'20127,858,820'Solid compositions suitable for oral administration containing non-hygroscopic salts of L-carnitine and the alkanoyl L-carnitines with taurine chloride and glycine chloride'20107,799,921'Stereoselective process and crystalline forms of a camptothecin'20107,713,956'Dealkylated derivatives of pyrrolo[2,1-b]benzothiazepines with atypical antipsychotic activity'20107,705,012'Camptothecins conjugated in position 7 to cyclic peptides as cytostatic agents'2010RE041226'Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase'20107,629,003'Esters of L-carnitine of alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds'20097,612,081'7-Polyaminoalkyl(oxy)iminomethylcamptothecins bearing protective groups'20097,589,099'7-t-butoxyiminomethylcamptothecin conjugated in position 20 with integrin antagonists'20097,585,519'Esters of L-carnitine or alkanoyl L-carnitines useful as cationic lipids for the intracellular delivery of pharmacologically active compounds'20097,572,778'Fluorocombretastatin and derivatives thereof'2009RE040861'Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase'20097,498,340'Esters in position 20 of camptothecins'20097,452,900'Esters in position 20 of camptothecins'20087,375,124'Use of α-phenylthiocarboxylic and α-phenyloxycarboxylic acids with serum-glucose-lowering and serum-lipid-lowering activity'20087,368,605'Variously substituted derivatives of guanidine, and their use as medicines with anti-diabetes and/or anti-obesity activity'20087,273,873'Camptothecins with a modified lactone ring'20077,169,808'Compounds useful for the preparation of medicaments with phosphodiesterase IV inhibitory activity'20077,084,166'Bis-heterocyclic compounds with antitumour and chemosensitising activity'20066,887,892'Tricyclic derivatives of indole with antiangiogenic activity'20056,822,115'Synthesis of (R) and (S)-aminocarnitine, (R) and (S)-4-phosphonium-3-amino-butanoate, (R) and (S) 3,4-diaminobutanoic acid, and their derivatives starting from D- and L-aspartic acid'20046,797,281'Esters of I-carnitine or alkanoyl I-carnitines'20046,566,552'Industrial process for the production of L-carnitine'20036,528,684'Synthesis of (R) and (S) -aminocarnitine and their derivatives starting from D- and L-aspartic acid'20036,476,243'Perfluorinated esters of alkanoyl L-carnitine for the preparation of cationic lipids for the intracellular delivery of pharmacologically active compounds'20026,465,515'Solid compositions suitable for oral administration containing non-hydroscopic salts of L-carnitine and alkanoyl L-carnitines'20026,444,701'Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase'20026,420,599'Chemical process for the stereoselective synthesis of R-(-)-carnitine'20026,369,073'Compounds having reversible inhibiting activity of carnitine palmitoyl-transferase'20026,337,349'Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate'20026,316,667'Process for the preparation of R-(-)-carnitine'20016,255,503'Water-soluble salts of dodecandioic acid and pharmaceutical and nutritional compositions containing same'20016,180,667'Esters of acyl L-carnitines and pharmaceutical compositions containing same for treating endotoxic shock'20016,130,249'Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate'20006,127,552'Process for producing (R)-3-hydroxy-4-butyrolactone useful for preparing (R)-carnitine'20006,124,360'Solid compositions suitable for oral administration comprising non hygroscopic salts of L-carnitine and alkanoyl-L-carnitine with 2-aminoethanesulfonic acid'20006,080,786'Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine choline tartrate'20006,051,608'Solid compositions suitable for oral administration comprising L-carnitine or alkanoyl-L-carnitine magnesium fumarate'20005,962,525'6,7-disubstituted-2-aminotetralines active as immunomodulators and pharmaceutical compositions containing same'19995,925,369'Bis alkanoyl esters of carnitine having bactericidal, fungicidal and antiprotozoal activity'19995,637,614'6,7-disubstituted-2-aminotetralines and pharmaceutical compositions containing the same'19975,625,085'Esters of acyl L-carnitines and pharmaceutical compositons containing same for treating endotoxic shock'19975,599,978'Process for manufacturing L-(-)-carnitine from a waste product having opposite configuration'19975,547,986'Ester of L-carnitine with gamma-hydroxybutyric acid and pharmaceutical compositions containing it for inhibiting neuronal degeneration and for the treatment of coma'19965,543,556'Esters of acyl l-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma'19965,534,549'Easters of acyl L-carnitines with gamma-hydroxybutyric acid and pharmaceutical compositions containing them for inhibiting neuronal degeneration and for the treatment of coma'19965,532,409'Process for producing R-aminocarnitine and S-aminocarnitine'19965,532,410'Process for manufacturing L(-)-carnitine from a waste product having opposite configuration'19965,525,627'Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity'19965,519,056'Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antimycotic activity'19965,498,633'Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity'19965,491,260'Process for manufacturing L-(-)-carnitine from derivatives having a configuration opposite to that of L-(-)-carnitine'19965,412,113'Process for manufacturing L-(-)-carnitine from a waste product having opposite configuration'19955,298,621'Oligopeptide derivatives of ipoxantine endowed with immunomodulating activity and pharmaceutical compositions containing same'19945,272,151'Aminoacyl and oligopeptidyl derivatives of allopurinol exhibiting immunostimulatory activity, and pharmaceutical formulations containing these substances'19935,227,496'Pyroglutamic acid derivatives as enhancers of learning processes and memory and pharmaceutical compositions comprising same'19935,192,759'Derivatives of 1,2,3,4-tetrahydronaphtylamine endowed with nootropic activity and pharmaceutical compositions containing same'19935,166,150'Pharmaceutical compositions comprising 3-amino-.epsilon.-caprolactames for enhancing the process of learning and memory'19925,155,102'1-alkyl-3-(acylamino)-.epsilon.-caprolactames as enhancers of learning and memory and pharmaceutical compositions containing same'19925,102,896'1-acyl-2-pyrrolidinones as enhancers of learning and memory'19925,061,725'(Pyrrolidin-2-one-1-yl) acetamides and enhancers of learning and memory pharmaceutical compositions comprising same'19915,053,424'2-(N-acyl)amino-6,7-dimethoxy tetralines, and pharmaceutical compositions having antihypertensive activity containing same'19915,047,433'N-alkyl derivatives of 2-amino-6,7-dimethoxy tetraline and pharmaceutical compositions having antihypertensive activity containing same'19915,041,643'Process for the production of R(+)-aminocarnitine and S(-)-aminocarnitine'19914,868,211'Derivatives of L-amino acyl L-carnitine, process for their preparation pharmaceutical compositions having hepatoprotecting activity containing same'19894,859,698'Novel class of acyl-derivatives of carnitine, process for preparing same and therapeutic use thereof'19894,812,478'Derivatives of L-amino acyl L-carnitine, process for their preparation and pharmaceutical compositions having hepatoprotecting activity containing same'19894,806,282'Process for preparing gamma-butyrobetaine'19894,766,222'Novel class of acyl-derivatives of carnitine process for preparing same and therapeutic use thereof'19884,600,794'Process for preparing gamma-dimethylamino L-beta hydroxy butyric acid'19864,599,447'Process for preparing L-norcarnitine hydrochloride'19864,593,043'Mercapto acyl-carnitines and pharmaceutical compositions containing same'19864,590,209'Alkoxy-acyl carnitines and pharmaceutical compositions containing same'19864,567,200'Esters of mercapto acyl-carnitines and pharmaceutical compositions containing same'19864,551,477'Esters of alkoxy-acylderivatives of carnitine and pharmaceutical compositions containing same'19854,518,613'Thioalkanoyl-carnitines, process for their preparation and mucolytic pharmaceutical compositions containing same'19854,510,318'Dithiodiacyl carnitines'19854,483,869'Thiocarnitines, process for their preparation and pharmaceutical compositions containing same'19844,343,947'Carnitinamides of optically active aminoacids'19824,240,984'Process for producing aromatic aldehydes'19804,239,702'Process for preparing aromatic aldehydes and alcohols'1980Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1980–2012Patents assigned to SIGMA TAU IND FARMACEUTI (76)· patent assignee history
1980–2012Based in Rome, IT· patent location history
2002–2005Based in Roma, IT· patent location history
2008–2009Patents assigned to IST NAZ STUD CURA DEI TUMORI (3)· patent assignee history
2008–2010Based in Pomezia, IT· patent location history
2012Patents assigned to ALPEGIANI MARCO (2)· patent assignee history
2012Patents assigned to CABRI WALTER (2)· patent assignee history
2012Patents assigned to CARMINATI PAOLO (2)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| SIGMA TAU IND FARMACEUTI | 76 | 1980–2012 |
| IST NAZ STUD CURA DEI TUMORI | 3 | 2008–2009 |
| ALPEGIANI MARCO | 2 | 2012 |
| CABRI WALTER | 2 | 2012 |
| CARMINATI PAOLO | 2 | 2012 |
Locations
| Location | Patents | Span |
|---|---|---|
| Rome, IT | 76 | 1980–2012 |
| Pomezia, IT | 4 | 2008–2010 |
| Roma, IT | 2 | 2002–2005 |